Nascent Pharma Holdings, Inc. Announces Name and Symbol Change
Can B Corp.'s Nascent Pharma Hires Fox Rothschild to Defend and Monetize Its Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million
Can B Corp. Announces Holding Company Reorganization With Nascent Pharma Holdings, Inc. to Become the Publicly-Traded Parent Company
Can B Corp. announces holding company reorganization with Nascent Pharma
Can B Corp. Merges with Nascent Pharma Holdings
CanadaBis Capital Triumphs in Q3 2024
Canadian CanadaBis Reports C$3.97M Net Revenue In Q3 2024, 26% Decline YoY
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
